Chemoinformaics analysis of 2,3-Dimethylnaphthalene
| Molecular Weight | 156.228 | nRot | 0 |
| Heavy Atom Molecular Weight | 144.132 | nRig | 11 |
| Exact Molecular Weight | 156.094 | nRing | 2 |
| Solubility: LogS | -5.055 | nHRing | 0 |
| Solubility: LogP | 4.334 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 24 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 12 | No. of Aromatic Carbocycles | 2 |
| nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 12 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 10 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 11 |
| nHA | 0 | APOL | 28.0415 |
| nHD | 0 | BPOL | 12.0385 |
| QED | 0.548 |
| Synth | 1.418 |
| Natural Product Likeliness | -0.351 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.023 |
| Pgp-sub | 0.324 |
| HIA | 0.003 |
| CACO-2 | -4.467 |
| MDCK | 0.0000193 |
| BBB | 0.793 |
| PPB | 0.965975 |
| VDSS | 0.997 |
| FU | 0.0337762 |
| CYP1A2-inh | 0.967 |
| CYP1A2-sub | 0.926 |
| CYP2c19-inh | 0.818 |
| CYP2c19-sub | 0.522 |
| CYP2c9-inh | 0.36 |
| CYP2c9-sub | 0.803 |
| CYP2d6-inh | 0.444 |
| CYP2d6-sub | 0.916 |
| CYP3a4-inh | 0.151 |
| CYP3a4-sub | 0.337 |
| CL | 10.235 |
| T12 | 0.248 |
| hERG | 0.045 |
| Ames | 0.765 |
| ROA | 0.035 |
| SkinSen | 0.833 |
| Carcinogencity | 0.824 |
| EI | 0.996 |
| Respiratory | 0.036 |
| NR-Aromatase | 0.018 |
| Antiviral | No |
| Prediction | 0.686036 |